Compare WhiteOak Capital Pharma and Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.17
1.87
NAV
₹13.85
₹38.59
Fund Started
16 Jan 2024
25 Jun 2018
Fund Size
₹556.42 Cr
₹6293.14 Cr
Exit Load
Exit load of 1%, if redeemed within 1 months.
Exit load of 1% if redeemed within 15 days.
1 Year
8.97%
5.59%
3 Year
-
26.04%
5 Year
-
15.55%
Equity
98.05%
97.62%
Cash
-1.83%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.35% |
JB Chemicals & Pharmaceuticals Ltd. | 8.90% |
Lupin Ltd. | 5.77% |
Divi's Laboratories Ltd. | 5.31% |
Apollo Hospitals Enterprise Ltd. | 4.24% |
Laurus Labs Ltd. | 3.93% |
Fortis Healthcare Ltd. | 3.85% |
Max Healthcare Institute Ltd. | 3.79% |
Glenmark Pharmaceuticals Ltd. | 3.17% |
Krishna Institute of Medical Sciences Ltd | 3.16% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
16 Jan 2024
25 Jun 2018
